|
|||||||||||||||||||||||||||||||||||||||
|
|
Refrences: 1. Vousden, KH. and Lu, X. Live or let die; The cell's response to p53 Nat Rev cancer 2:594-604, 2002. 2. Polyak, K, Xia, Y, Zwieier, J. L. Kinzler, K.W. and Vogelstein, B. A.;Model for p53- induced apoptosis. Nature, 389: 300-305, 1997. 3. Vogelstein, B. Lance, D. and Levine, A. J.; Surfing the p53 network nature, 408: 307- 310, 2000. 4. Ellegren, H.; Microsatellite mutation in germline; implications for evolutionary inference. Trends Genet, 16:551-558, 2000. 5. F. Frasca, A. Rustighi, R. Malaguarnera, S. Altamura, P. Vigneri, G. Del Sal, V. Giancotti, V. Pezzino, R. Vigneri, and G. Manfioletti; HMGA1 Inhibits the Function of p53 Family Members in Thyroid Cancer Cells. (2006) Cancer Res. 66 , 2980-2989. 6. May, P. and May E;Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene 1999, 18: 7621-7636. 7. Guimaraes D.P. and Hainaut P: TP53: a key gene in human cancer. Biochimie 2002, 84: 83-93. 8. Kim E, Deppert W: Transcriptional activities of mutant p53: when mutations are more than a loss. J Cell Biochem 2004, 93: 878-886. 9. Gonzalez de Aguilar, J.L. et al.2000. Alteration of the Bcl-x/Bax ratio in a transgenic mouse model of amyotrophic lateral sclerosis: evidence for the implication of the p53 signaling pathway. Neurobiol. Dis. 7 :406-415. 10. Gurney EG, Harrison RO and Fenno J (1980) Monoclonal antibodies against simian virus 40 T antigens : evidence for distinct subclasses of large T antigen and for similaraties among nonviral T antigens. J. Virol. 34 : 752-763. 11. Harlow E, Crawford LV, Pim DC and Williamson NM (1981) Monoclonal antibodies specific for Simian Virus 40 tumor antigens. J. Virol. 861-869. 12.Wade-Evans A and Jenkins JR (1985) Precise epitope mapping of the murine transformation-associated protein, p53. EMBO J. 4 : 699-706. 13.Anensen N, Oyan AM, Bourdon JC, Kalland KH, Bruserud O, Gjertsen BT (2006) A distinct p53 protein isoform signature reflects the onset of induction chemotherapy for acute myeloid leukemia. Clin Cancer Res 12: 3985- 3992 14. Boldrup L, Bourdon JC, Coates PJ, Sjostrom B, Nylander K (2007) Expression of p53 isoforms in squamous cell carcinoma of the head and neck. Eur J Cancer 43: 617-623 15. Bourdon JC, Deguin-Chambon V, Lelong JC, Dessen P, May P, Debuire B, May E (1997) Further characterisation of the p53 responsive element -identification of new candidate genes for trans-activation by p53.Oncogene 14: 85-94 16. Ghosh A, Stewart D, Matlashewski G (2004) Regulation of human p53 activity and cell localization by alternative splicing. Mol Cell Biol 24: 7987-7997 17. H.M. Berman, K. Henrick, H. Nakamura (2003): Announcing the worldwide Protein Data Bank. Nature Structural Biology 10 (12), p. 980 . 18.
Bernstein FC, Koetzle TF, Williams GJ, Meyer Jr EF, Brice MD, Rodgers
JR, Kennard O, Shimanouchi T, Tasumi M. The Protein Data Bank: a computer-based
archival file for macromolecular structures. J Mol Biol 1977;112:535-542. 19.Balint EE, Vousden KH. (2001). Br. J. Cancer, 85: 1813-1823. 20. Baptiste N, Friedlander P, Chen X, Prives C. (2002). Oncogene, 21: 9-21. 21. Hainaut P, Hollstein M. (2000). Adv. Cancer Res., 77: 81-137. 22. Schreiber M, Kolbus A, Piu F, Szabowski A, Mohle-Steinlein U, Tian J, Karin M, Angel P, Wagner EF. (1999). Gene Dev., 13: 607-619. 23. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, Andrews NC, Caput D, McKeon F. (1998). Mol. Cell, 2: 305-316. 24. Hartl, D. L., Jones, E. W. Genetic Analysis of Genes and Genomes.John and Bartlett Publishers: Boston, 2000. |
|||||||||||||||||||||||||||||||||||||
| © IBI Biosolutions Pvt. Ltd. INDIA | |||||||||||||||||||||||||||||||||||||||